Correlation Between Salesforce and Acasti Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Acasti Pharma, you can compare the effects of market volatilities on Salesforce and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Acasti Pharma.

Diversification Opportunities for Salesforce and Acasti Pharma

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Salesforce and Acasti is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Salesforce i.e., Salesforce and Acasti Pharma go up and down completely randomly.

Pair Corralation between Salesforce and Acasti Pharma

Considering the 90-day investment horizon Salesforce is expected to generate 1.72 times less return on investment than Acasti Pharma. But when comparing it to its historical volatility, Salesforce is 2.87 times less risky than Acasti Pharma. It trades about 0.23 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  264.00  in Acasti Pharma on August 29, 2024 and sell it today you would earn a total of  73.00  from holding Acasti Pharma or generate 27.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy65.63%
ValuesDaily Returns

Salesforce  vs.  Acasti Pharma

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Acasti Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Acasti Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively weak basic indicators, Acasti Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Salesforce and Acasti Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Acasti Pharma

The main advantage of trading using opposite Salesforce and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.
The idea behind Salesforce and Acasti Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world